AcelRx Pharmaceuticals ACRX
$ 0.86
7.5%
Quarterly report 2024-Q3
added 11-13-2024
AcelRx Pharmaceuticals Financial Statements 2011-2024 | ACRX
Annual Financial Statements AcelRx Pharmaceuticals
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
12.3 M | 4.73 M | 2.88 M | 188 M | 136 M | 144 M | 91.4 M | 118 M | 160 M | 291 M | 466 M | 113 M | 46.7 M |
Shares |
14.3 M | 7.39 M | 5.99 M | 85.3 M | 79.2 M | 58.4 M | 46.9 M | 45.3 M | 44.3 M | 43.4 M | 39.7 M | 22.1 M | 17.3 M |
Historical Prices |
0.86 | 0.64 | 0.48 | 2.2 | 1.7 | 2.46 | 1.9 | 2.65 | 3.61 | 6.7 | 11.4 | 5.37 | 3.3 |
Net Income |
-18.4 M | 47.8 M | -35.1 M | -40.4 M | -53.2 M | -47.1 M | -51.5 M | -43.2 M | -24.4 M | -33.4 M | -23.4 M | -33.4 M | -20.1 M |
Revenue |
651 K | 1.77 M | 2.82 M | 5.42 M | 2.29 M | 2.15 M | 8 M | 17.4 M | 19.3 M | 5.22 M | 29.5 M | 2.39 M | 1.07 M |
Cost of Revenue |
- | - | 3.75 M | 6.03 M | 6.81 M | 3.98 M | 10.7 M | 12.3 M | - | - | - | - | - |
Gross Profit |
- | - | - | -616 K | -4.52 M | -1.82 M | -2.66 M | 5.04 M | 17.5 M | - | 29.5 M | - | 1.07 M |
Operating Income |
-16.9 M | -25.3 M | -36 M | -41 M | -54.2 M | -35.7 M | -38.7 M | -32 M | -20 M | -37.6 M | -6.67 M | - | - |
Interest Expense |
134 K | 1.12 M | 2.29 M | 3.3 M | 2.54 M | 2.22 M | 3.32 M | 2.77 M | 2.98 M | 2.64 M | 1.52 M | 2.28 M | 2.31 M |
EBITDA |
-16.6 M | -23.7 M | -34 M | -39.1 M | -52.5 M | -35.2 M | -36.9 M | -29.9 M | -17.2 M | -36.8 M | -6.07 M | -29.1 M | -18.8 M |
Operating Expenses |
- | - | - | 40.3 M | 49.7 M | 33.9 M | 36 M | 37 M | 36.7 M | 42.9 M | 36.2 M | 32.1 M | 20.4 M |
General and Administrative Expenses |
12 M | 17 M | 30.9 M | 36.3 M | 45 M | 20.8 M | 16.6 M | 15.6 M | 14.2 M | 18.3 M | 9.88 M | 7.2 M | 6.8 M |
All numbers in USD currency
Quarterly Income Statement AcelRx Pharmaceuticals
2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
26.2 M | 26.2 M | 24.7 M | 17 M | 16.8 M | 10.9 M | 10.9 M | 8.24 M | 7.38 M | 7.36 M | 146 M | 6.84 M | 5.96 M | 119 M | 113 M | 98.8 M | 87.9 M | 80.7 M | 80.1 M | 79.6 M | 79.5 M | 78.9 M | 78.8 M | 78.8 M | 60 M | 51.8 M | 50.9 M | 50.9 M | 46.4 M | 45.4 M | 45.3 M | 45.3 M | 45.3 M | 45.3 M | 45.3 M | 45.3 M | 44.4 M | 44.3 M | 43.9 M | 43.7 M | 43.5 M | 43.3 M | 43.2 M | 43.1 M | 41.5 M | 37.3 M | 37.1 M | 37.1 M | 22.6 M | 20.6 M | 19.6 M | 19.6 M | 19.5 M | 19.4 M | 19.6 M |
Net Income |
-3.35 M | -3.83 M | -3.95 M | - | -1.36 M | -4.37 M | -8.15 M | - | -6.75 M | 70.7 M | -8.67 M | - | -8.38 M | -9.85 M | -8.96 M | - | -8.93 M | -6.61 M | -15.9 M | -14.4 M | -12.7 M | -12.4 M | -13.7 M | -12.6 M | -12.5 M | -10.5 M | -11.6 M | -9.88 M | -13 M | -13.1 M | -15.6 M | -9.68 M | -11.4 M | -11.1 M | -11 M | -10.5 M | 5.07 M | -8.9 M | -10 M | -13.8 M | 671 K | -10.6 M | -9.63 M | 17.8 M | -11 M | -17.4 M | -12.8 M | -10.5 M | -8.58 M | -7.19 M | -7.06 M | -6.37 M | -5.76 M | -4.76 M | -3.2 M |
Revenue |
- | - | - | - | 117 K | 253 K | - | - | 507 K | 570 K | 442 K | - | 1.86 M | 443 K | 511 K | - | 1.37 M | 2.92 M | 386 K | 475 K | 608 K | 941 K | 265 K | 613 K | 377 K | 818 K | 343 K | 740 K | 1.49 M | 2.66 M | 3.11 M | 6.44 M | 3.37 M | 4.53 M | 3.02 M | 1.73 M | 15.4 M | 1.92 M | 181 K | 226 K | 4.82 M | 71 K | 95 K | 27.6 M | 548 K | 407 K | 940 K | 1.68 M | 166 K | 224 K | 329 K | 624 K | 408 K | 40 K | - |
Cost of Revenue |
- | - | - | - | - | - | - | - | 569 K | 876 K | 784 K | - | 439 K | 1.04 M | 1.04 M | - | 1.85 M | 1.37 M | 1.51 M | - | 2.15 M | 1.81 M | 1.23 M | - | 875 K | 749 K | 1.11 M | - | 2.03 M | 3.54 M | 4.12 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
- | - | - | - | - | - | -5.33 M | - | -6.63 M | -13.6 M | -4.94 M | - | -8.63 M | -10 M | -9.14 M | - | -9.04 M | -6.83 M | -15.8 M | - | -13.5 M | -13.4 M | -12.3 M | - | -9.33 M | -7.15 M | -8.27 M | - | -8.86 M | -9.94 M | -12.1 M | - | -7.98 M | -8.32 M | -8.52 M | - | 7.1 M | -8.12 M | -11.4 M | - | -5.07 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Interest Expense |
- | - | - | - | - | 15 K | 119 K | - | 245 K | 293 K | 390 K | - | 538 K | 614 K | 672 K | - | 824 K | 872 K | 855 K | - | 828 K | 500 K | 376 K | - | 529 K | 586 K | 643 K | - | 919 K | 903 K | 774 K | - | 702 K | 687 K | 680 K | - | 713 K | 777 K | 806 K | - | 816 K | 530 K | 472 K | - | 348 K | 403 K | 454 K | - | 573 K | 598 K | 594 K | - | 377 K | 156 K | 1.36 M |
EBITDA |
- | - | - | - | - | - | -5.07 M | - | -5.33 M | -12.7 M | -4.52 M | - | -7.12 M | -8.99 M | -8.69 M | - | -7.57 M | -5.86 M | -15.4 M | - | -12.4 M | -12.6 M | -12 M | - | -8.89 M | -6.86 M | -8.12 M | - | -7.47 M | -8.99 M | -11.6 M | - | -6.43 M | -7.29 M | -8.01 M | - | 8.61 M | -7.13 M | -10.9 M | - | -4.6 M | 318 K | 162 K | - | 439 K | 288 K | 141 K | - | 467 K | 336 K | 164 K | - | 348 K | 232 K | 117 K |
Operating Expenses |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 15.5 M | 14.1 M | 14.3 M | 12.6 M | 11.6 M | 9.7 M | 7.97 M | 8.61 M | 8.55 M | 10.3 M | 12.6 M | 15.2 M | 13.6 M | 11.3 M | 12.9 M | 11.5 M | 9.27 M | 8.32 M | 10 M | 11.6 M | 12 M | 9.89 M | 12.3 M | 8.64 M | 7.62 M | 8.86 M | 8.18 M | 11.5 M | 9.7 M | 8.36 M | 7.17 M | 6.88 M | - | 5.81 M | 4.66 M | 3.54 M |
General and Administrative Expenses |
1.7 M | 2.36 M | 2.8 M | - | 2.25 M | 2.67 M | 4.28 M | - | 3.72 M | 3.96 M | 4.1 M | - | 8.64 M | 8.69 M | 7.64 M | - | 7.6 M | 7.58 M | 13.3 M | - | 10.9 M | 11.3 M | 9.98 M | - | 5.19 M | 3.94 M | 3.98 M | - | 4.41 M | 4.16 M | 4.14 M | - | 4.14 M | 3.6 M | 3.78 M | - | 2.93 M | 2.74 M | 4.52 M | - | 4.65 M | 5.05 M | 3.92 M | - | 2.31 M | 2.07 M | 2.19 M | - | 1.41 M | 1.78 M | 2.1 M | - | 1.87 M | 1.63 M | 1.59 M |
All numbers in USD currency